{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "7889303", "DateCompleted": {"Year": "1995", "Month": "04", "Day": "19"}, "DateRevised": {"Year": "2019", "Month": "05", "Day": "12"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0007-1188", "JournalIssue": {"Volume": "113", "Issue": "4", "PubDate": {"Year": "1994", "Month": "Dec"}}, "Title": "British journal of pharmacology", "ISOAbbreviation": "Br J Pharmacol"}, "ArticleTitle": "Antimuscarinic action of liriodenine, isolated from Fissistigma glaucescens, in canine tracheal smooth muscle.", "Pagination": {"StartPage": "1464", "EndPage": "1470", "MedlinePgn": "1464-70"}, "Abstract": {"AbstractText": ["1. The antimuscarinic properties of liriodenine, isolated from Fissistigma glaucescens, were compared with methoctramine (cardioselective M2 antagonist) and 4-diphenylacetoxy-N-methylpiperidine (4-DAMP, smooth muscle selective M3 antagonist) by radioligand binding tests, functional tests and measurements of second messenger generation in canine cultured tracheal smooth muscle cells. 2. Liriodenine, pirenzepine, methoctramine and 4-DAMP displaced [3H]-N-methyl scopolamine ([3H]-NMS) binding in a concentration-dependent manner with Ki values of 2.2 +/- 0.4 x 10(-6), 3.3 +/- 0.7 x 10(-7), 8.9 +/- 2.3 x 10(-8) and 2.3 +/- 0.6 x 10(-9) M, respectively. The curves for competitive inhibition of [3H]-NMS with liriodenine, methoctramine and 4-DAMP were best fitted according to a two site model of binding, but pirenzepine was best fitted according to a model with one site. 3. Liriodenine and 4-DAMP displayed a high affinity for blocking tracheal contraction (pKB = 5.9 and 9.1, respectively) and inositol phosphate formation (pKB = 6.0 and 8.9, respectively), but a low affinity for antagonism of cyclic AMP inhibition (pKB = 4.7 and 7.8, respectively). 4. Methoctramine blocked cyclic AMP inhibition with a high affinity (pKB = 7.4), but it antagonized tracheal contraction and inositol phosphate formation with a low affinity (pKB = 6.1 and 6.0, respectively). 5. In conclusion, both M2 and M3 muscarinic receptor subtypes coexist in canine tracheal smooth muscle and are coupled to the inhibition of cyclic AMP formation and phosphoinositide breakdown, respectively. The antimuscarinic characteristics of liriodenine are similar to those of 4-DAMP. It may act as a selective M3 receptor antagonist in canine tracheal smooth muscle."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacological Institute, College of Medicine, National Taiwan University, Taipei."}], "LastName": "Lin", "ForeName": "C H", "Initials": "CH"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Yang", "ForeName": "C M", "Initials": "CM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Ko", "ForeName": "F N", "Initials": "FN"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Wu", "ForeName": "Y C", "Initials": "YC"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Teng", "ForeName": "C M", "Initials": "CM"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Br J Pharmacol", "NlmUniqueID": "7502536", "ISSNLinking": "0007-1188"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Adenylyl Cyclase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Aporphines"}, {"RegistryNumber": "0", "NameOfSubstance": "Diamines"}, {"RegistryNumber": "0", "NameOfSubstance": "Inositol Phosphates"}, {"RegistryNumber": "0", "NameOfSubstance": "Muscarinic Antagonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Parasympatholytics"}, {"RegistryNumber": "0", "NameOfSubstance": "Phosphatidylinositols"}, {"RegistryNumber": "0", "NameOfSubstance": "Piperidines"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Muscarinic"}, {"RegistryNumber": "81405-11-0", "NameOfSubstance": "4-diphenylacetoxy-1,1-dimethylpiperidinium"}, {"RegistryNumber": "8Y164V895Y", "NameOfSubstance": "Carbachol"}, {"RegistryNumber": "E0399OZS9N", "NameOfSubstance": "Cyclic AMP"}, {"RegistryNumber": "E134R7X4O9", "NameOfSubstance": "liriodenine"}, {"RegistryNumber": "EC 4.6.1.1", "NameOfSubstance": "Adenylyl Cyclases"}, {"RegistryNumber": "NVJ76B897D", "NameOfSubstance": "methoctramine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adenylyl Cyclase Inhibitors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Adenylyl Cyclases"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Aporphines"}, {"QualifierName": ["drug effects"], "DescriptorName": "Binding, Competitive"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Carbachol"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cyclic AMP"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Diamines"}, {"QualifierName": [], "DescriptorName": "Dogs"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Hydrolysis"}, {"QualifierName": ["metabolism"], "DescriptorName": "Inositol Phosphates"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Muscarinic Antagonists"}, {"QualifierName": ["drug effects"], "DescriptorName": "Muscle Contraction"}, {"QualifierName": ["drug effects"], "DescriptorName": "Muscle, Smooth"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Parasympatholytics"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phosphatidylinositols"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Piperidines"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Receptors, Muscarinic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Trachea"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Biochem Pharmacol. 1973 Dec 1;22(23):3099-108", "ArticleIdList": ["4202581"]}, {"Citation": "Br J Pharmacol. 1994 Sep;113(1):275-81", "ArticleIdList": ["7812621"]}, {"Citation": "Anal Biochem. 1980 Sep 1;107(1):220-39", "ArticleIdList": ["6254391"]}, {"Citation": "Life Sci. 1982 Dec 27;31(26):2991-8", "ArticleIdList": ["6897666"]}, {"Citation": "Life Sci. 1983 Jun 27;32(26):3001-11", "ArticleIdList": ["6688111"]}, {"Citation": "J Biol Chem. 1984 Mar 25;259(6):3777-81", "ArticleIdList": ["6323440"]}, {"Citation": "J Cell Biol. 1985 Mar;100(3):807-13", "ArticleIdList": ["3972897"]}, {"Citation": "Life Sci. 1986 May 5;38(18):1663-72", "ArticleIdList": ["3754611"]}, {"Citation": "Mol Pharmacol. 1987 Jul;32(1):91-9", "ArticleIdList": ["3600616"]}, {"Citation": "J Pharmacol Exp Ther. 1987 Jul;242(1):257-62", "ArticleIdList": ["3612532"]}, {"Citation": "Nature. 1988 Aug 4;334(6181):434-7", "ArticleIdList": ["2841607"]}, {"Citation": "J Biol Chem. 1988 Dec 5;263(34):18397-403", "ArticleIdList": ["2848036"]}, {"Citation": "Mol Pharmacol. 1989 Apr;35(4):469-76", "ArticleIdList": ["2704370"]}, {"Citation": "Trends Neurosci. 1989 Apr;12(4):148-51", "ArticleIdList": ["2470172"]}, {"Citation": "Neuron. 1988 Jul;1(5):403-10", "ArticleIdList": ["3272174"]}, {"Citation": "Br J Pharmacol. 1990 Feb;99(2):293-6", "ArticleIdList": ["2158372"]}, {"Citation": "Annu Rev Pharmacol Toxicol. 1990;30:633-73", "ArticleIdList": ["2188581"]}, {"Citation": "Life Sci. 1990;47(7):611-8", "ArticleIdList": ["2402185"]}, {"Citation": "Mol Pharmacol. 1990 Nov;38(5):689-97", "ArticleIdList": ["2172776"]}, {"Citation": "J Auton Pharmacol. 1991 Feb;11(1):51-61", "ArticleIdList": ["2030109"]}, {"Citation": "Br J Pharmacol. 1991 Nov;104(3):613-8", "ArticleIdList": ["1665744"]}, {"Citation": "J Pharmacol Exp Ther. 1992 Jul;262(1):119-26", "ArticleIdList": ["1625190"]}, {"Citation": "Pharmacol Ther. 1993 Jun;58(3):319-79", "ArticleIdList": ["7504306"]}, {"Citation": "Trends Pharmacol Sci. 1994 Apr;15(4):114-9", "ArticleIdList": ["8016895"]}, {"Citation": "Proc Natl Acad Sci U S A. 1974 May;71(5):1725-9", "ArticleIdList": ["4151898"]}], "ReferenceList": []}], "History": [{"Year": "1994", "Month": "12", "Day": "1"}, {"Year": "1994", "Month": "12", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1994", "Month": "12", "Day": "1", "Hour": "0", "Minute": "0"}, {"Year": "1995", "Month": "12", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["7889303", "PMC1510520", "10.1111/j.1476-5381.1994.tb17161.x"]}}]}